Staff editor
Industry
Sponsored by
Mapping microbial reality by indirect or direct methods? Vermicon AG's position.
The investment signals a significant advancement in developing innovative treatments for women's reproductive health issues.
Ferring Pharmaceuticals and PharmaBiome announced a comprehensive research and development collaboration today.
Silvia Barbaresi, molecular biologist, researcher and nutritionist at Ghent Univerity, discusses how sports and physical activity in general impact on gut microbiota composition.
In a significant move to expand its immuno-oncology portfolio, Boehringer Ingelheim has acquired T3 Pharmaceuticals AG, a Swiss biotech company specializing in bacterial cancer therapy.
Epatrex, a new nutraceutical compound formulated as a three-layer tablet containing the probiotic Lactobacillus casei LC-XCAL.
Alessio Fasano, pediatric gastroenterologist and researcher at Harvard Medical School, discusses how celiac disease could become a model to study the link between gut microbiome and disease pathogenesis.
The therapy, combining human milk oligosaccharides (HMOs) and a specific gut bacteria strain, represents not only a scientific breakthrough but also holds substantial economic implications.
Gianluca Ianiro, from Gemelli Hospital in Rome, discusses the future of microbiota modulation, with a focus on Microbial Therapeutics.
Industry
Sponsored by
Smiling ear to ear, supporting healthy teeth and mouth.
